• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Medtronic Operating Toward Renewed Gains

After correction, the medical device maker could see longer-term gains to the $150-$161 area.
By BRUCE KAMICH
Oct 24, 2019 | 01:36 PM EDT
Stocks quotes in this article: MDT

Jim Cramer said on "Mad Money" on Wednesday that he's a fan of the medical device company Medtronic PLC (MDT) , which has recently pulled back to just 18-times earnings. He said the recent weakness is a buying opportunity, especially after Medtronic's acquisition of Mazor Robotics. Let's check out the charts of MDT.  

 
In this daily bar chart of MDT, below, we can see that prices have been correcting lower from late September. MDT is below the cresting 50-day moving average line, but still well above the rising 200-day moving average line. Trading volume has declined during this pullback, and the On-Balance-Volume (OBV) only shows a modest decline, which suggests that longs have largely stayed with their positions.
 
The trend-following Moving Average Convergence Divergence (MACD) oscillator just fell below the zero-line, so it will not take much of a rally to reverse direction. 
 
 
In this weekly bar chart of MDT, below, we see a mostly bullish set-up. Prices are above the rising 40-week moving average line. The weekly OBV line has been strong and bullish from April, and that helps confirm the price gains. The MACD oscillator is just now crossing to the downside for a take profits sell signal.
 
 
In this weekly close-only Point and Figure chart of MDT, below, we can see that the software is projecting a possible, or potential, upside price objective of $161. 
 
 
Bottom line strategy: MDT should find buying support towards $104. Traders could use this test of support as a place to go long, or risk to $100 and look for longer-term gains to the $150-$161 area.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Technical Analysis | Health Care Equipment & Services | Healthcare | Mad Money | Stocks

More from Stocks

Bearish Bets: 2 Stocks You Should Consider Shorting This Week

Bob Lang
Dec 15, 2019 12:00 PM EST

These well-known names are showing both technical and quantitative deterioration.

Get a 6% Yield for This Best In Class MLP

Bob Ciura
Dec 14, 2019 1:00 PM EST

Hey income investors, this MLP has increased its distribution for 61 consecutive quarters.

To Be a Great Trader, Plan on Losing Money

James "Rev Shark" DePorre
Dec 14, 2019 10:00 AM EST

Losses are simply a function of the trading process and are not an indication of failure.

A Quiet Conclusion to a Dramatic and Contentious Issue

James "Rev Shark" DePorre
Dec 13, 2019 4:24 PM EST

This market has such a positive brew that has to make you at least a little apprehensive.

Put These 2 Stocks on Your Radar for the Week Ahead

Timothy Collins
Dec 13, 2019 1:00 PM EST

While both have 'Technologies' in their name, they don't share the same space.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 10:10 AM EST BOB LANG

    Banking a Big Winner in SRPT, Rolling Up

    Nov. 20 here on the CC, I mentioned buying some Ma...
  • 10:36 AM EST GARY BERMAN

    Fibocall: How High Can Crude Go?

    On crude: I am looking for higher, but please b...
  • 08:20 AM EST BOB LANG

    Webinar Time - Talkin' Calendars, Butterflys

    join me later today after the market close as we t...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2019 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login